Vitamin K Administration Based on INR/PT Levels
For warfarin-associated elevated INR without major bleeding, vitamin K should be given when INR is ≥5, with dosing and route determined by the specific INR level and bleeding risk. The decision to administer vitamin K depends on both the INR value and clinical context, not PT alone, as INR is the standardized measure for warfarin monitoring.
Algorithm for Vitamin K Administration
INR Above Therapeutic Range but <5
- No vitamin K needed if no bleeding and no urgent surgery planned 1
- Simply reduce or hold warfarin dose and resume at lower dose when INR approaches therapeutic range
INR 5-9 Without Bleeding
- Omit 1-2 warfarin doses if patient has no bleeding risk factors 1
- Give oral vitamin K 1-2.5 mg if patient has increased bleeding risk 1
- For urgent surgery/procedures: oral vitamin K 2-5 mg with INR reduction expected within 24 hours 1
INR ≥9 Without Bleeding
- Give oral vitamin K 3-5 mg 1
- Expect INR reduction within 24-48 hours
- Monitor INR closely and repeat vitamin K as necessary
Major Bleeding or Life-Threatening Hemorrhage
- Give IV vitamin K 10 mg by slow infusion (over 15-30 minutes) 1
- Must be supplemented with 4-factor prothrombin complex concentrate (4F-PCC) 2
- Dosed by INR and weight: INR 2-<4 at 25 U/kg, INR 4-6 at 35 U/kg, INR >6 at 50 U/kg (max 5,000 units) 2
- If 4F-PCC unavailable, use fresh frozen plasma 2
- May repeat vitamin K every 12 hours as needed 1
Route of Administration Considerations
Oral vitamin K is preferred for non-emergent situations as it is safer, more convenient, and less expensive than parenteral forms 1. Research demonstrates that 1 mg oral vitamin K reliably reduces INR from 4.5-10 to therapeutic range within 24 hours 3.
IV vitamin K should be reserved for:
- Life-threatening or major bleeding requiring rapid reversal (4-6 hours vs 18-24 hours for oral) 2, 1
- Patients unable to take oral medications
- Must be given by slow IV infusion over 15-30 minutes to minimize anaphylaxis risk 2, 1
Subcutaneous vitamin K is not recommended due to unpredictable absorption 2
Critical Pitfalls to Avoid
Never give vitamin K alone for major bleeding: Vitamin K takes 4-6 hours (IV) to 24 hours (oral) to work 2, 1. Major bleeding requires immediate factor repletion with 4F-PCC plus vitamin K 2
Don't routinely give vitamin K for INR 4.5-5: This range often corrects with dose adjustment alone, and unnecessary vitamin K can cause warfarin resistance 1
Avoid rapid IV push: Current vitamin K preparations are safer than older formulations, but slow infusion over 15-30 minutes remains essential 2
Don't use PT values alone: Always use INR for warfarin monitoring decisions, as PT varies by laboratory reagent 1
Dosing Summary from FDA Label
The FDA-approved dosing for anticoagulant-induced prothrombin deficiency is 2.5-10 mg initially, up to 25 mg in some cases (rarely 50 mg) 4. Frequency and amount of subsequent doses should be determined by PT/INR response at 6-8 hours post-administration 4.
Special Considerations
High-dose vitamin K (≥10 mg) can cause prolonged warfarin resistance lasting days to weeks. If warfarin needs to be resumed after high-dose vitamin K, bridging with heparin may be necessary until vitamin K effects dissipate and warfarin responsiveness returns 1.
Recent evidence suggests that in non-life-threatening bleeding with INR 5-6, IV vitamin K alone may provide adequate hemostasis within 5 hours, potentially avoiding the need for PCC in selected cases 5. However, this approach requires close monitoring and repeat INR testing.